Watchlist Price Alert

Alto Neuroscience Inc. (ANRO)

NYSE: ANRO · Real-Time Price · USD

2.24

-0.07 (-3.03%)

At close: Jun 17, 2025, 3:59 PM

2.15

-4.24%

After-hours: Jun 17, 2025, 06:00 PM EDT

Alto Neuroscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-61.43M	-36.3M	-27.71M	-9.19M
Depreciation & Amortization	502K	373K	342K	145K
Stock-Based Compensation	7.63M	2.89M	1.76M	227K
Other Working Capital	3.54M	-391K	2.42M	255K
Other Non-Cash Items	1.81M	291K	632K	125K
Deferred Income Tax	n/a	n/a	n/a	n/a
Change in Working Capital	4.06M	-698K	4.58M	-572K
Operating Cash Flow	-47.42M	-33.45M	-20.39M	-9.26M
Capital Expenditures	-2.08M	-470K	-732K	-680K
Cash Acquisitions	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a
Investing Cash Flow	-2.08M	-470K	-732K	-680K
Debt Repayment	n/a	n/a	9.82M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.89M	-2.05M	-341K	-205K
Financial Cash Flow	135.69M	68.13M	43.79M	31.69M
Net Cash Flow	86.18M	34.2M	22.64M	21.7M
Free Cash Flow	-49.5M	-33.92M	-21.13M	-9.94M